Mesenteric vascular insufficiency is a serious medical condition that may lead to bowel infarction, morbidity, and mortality that may approach 50%. Recommended therapy for acute mesenteric ischemia includes aspiration embolectomy, transcatheter thrombolysis, and angioplasty with or without stenting for the treatment of underlying arterial stenosis. Nonocclusive mesenteric ischemia may respond t...

OBJECTIVE Acute mesenteric ischemia, one of the causes of acute abdominal pain due to occlusion of the superior mesenteric artery, has a fatal course as a result of intestinal necrosis. There is no specific laboratory test to diagnose acute mesenteric ischemia. The basis of treatment in cases of acute mesenteric ischemia is composed of early diagnosis, resection of intestinal sections with infa...

BACKGROUND Non-occlusive mesenteric ischemia (NOMI) is not uncommon in intensive care units. NOMI indicate ischemia of bowel wall without any significant obstruction in the mesenteric arteries. Common causes of NOMI include sepsis, severe cardiac failure, and any critical illness. Mesenteric circulation can suffer due to low cardiac output leading to very unfortunate outcomes. Pneumatosis Intes...

Gonzalez EA, Hunter R, Kozar RA, Moore FA. Poloxamer 188-Hypertonic saline provides optimal ileal protection after mesenteric ischemia/reperfusion. J Surg Res 2007;137;337 Gonzalez EA, Hunter R, Kozar RA, Weisbrodt N, Field E, Moore FA.Poloxamer 188 resuscitation after mesenteric ischemia/reperfusion abrogates neutrophil mediated ileal mucosal injury. Journal of Trauma 2006;61:514.

INTRODUCTION Insufficient mesenteric perfusion is a dramatic complication in critically ill patients. Hydrogen sulfide, a newly recognized endogenous gaseous mediator, acts as an intestinal vasoactive agent and seems to protect against mesenteric ischemic damage. We investigated whether sodium hydrogen sulfide, a hydrogen sulfide donor, can improve mesenteric perfusion in an experimental model ...

INTRODUCTION Acute mesenteric ischemia (AMI) is a rare but very severe complication of heart surgery, due especially to the delay in setting the correct diagnosis and choosing the appropriate treatment. There are 4 types, but the most frequent is nonocclusive mesenteric ischemia (NOMI). The main mechanism is represented by great decrease or maldistribution of the splenic blood flow, with negati...

Introduction Non-occlusive mesenteric ischemia (NOMI) is an acute mesenteric circulatory disorder that, in contrast to mesenteric arterial occlusion induced by blockage of blood flow by emboli and thrombi, is not caused by organic occlusion of blood vessels. 1 Good outcomes in NOMI are observed with early recognition and treatment. 1-2 The early symptoms and characteristics of NOMI, however, ar...

OBJECTIVES Previous studies have demonstrated that ischemia-modified albumin (IMA) is a useful marker for the diagnosis of ischemic events. This study aimed to determine the value of ischemia-modified plasma albumin in the early diagnosis of acute mesenteric ischemia in an experimental model. METHODS The study was performed on 32 Wistar albino rats divided into control (n = 8), sham (n = 8), ...